Bessemer Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130M Sell
1,081,897
-972,240
-47% -$112M 0.2% 123
2025
Q4
$216M Buy
2,054,137
+526,293
+34% +$49.4M 0.33% 69
2025
Q3
$128M Buy
1,527,844
+37,142
+2% +$3.06M 0.2% 131
2025
Q2
$118M Sell
1,490,702
-9,206
-0.6% -$732K 0.19% 135
2025
Q1
$135M Sell
1,499,908
-128,225
-8% -$12M 0.24% 110
2024
Q4
$162M Sell
1,628,133
-272,785
-14% -$28.1M 0.26% 101
2024
Q3
$216M Buy
1,900,918
+16,717
+0.9% +$1.99M 0.36% 74
2024
Q2
$233M Sell
1,884,201
-42,824
-2% -$5.52M 0.41% 59
2024
Q1
$254M Buy
1,927,025
+285,852
+17% +$35.2M 0.46% 49
2023
Q4
$179M Buy
1,641,173
+16,749
+1% +$1.74M 0.35% 75
2023
Q3
$167M Sell
1,624,424
-8,854
-0.5% -$954K 0.37% 75
2023
Q2
$188M Buy
1,633,278
+169,319
+12% +$19.2M 0.4% 64
2023
Q1
$156M Buy
1,463,959
+13,388
+0.9% +$1.45M 0.37% 77
2022
Q4
$161M Buy
1,450,571
+16,450
+1% +$1.68M 0.39% 77
2022
Q3
$124M Buy
1,434,121
+23,896
+2% +$2.13M 0.32% 90
2022
Q2
$129M Buy
1,410,225
+52,934
+4% +$4.69M 0.32% 92
2022
Q1
$111M Buy
1,357,291
+28,744
+2% +$2.27M 0.23% 127
2021
Q4
$102M Sell
1,328,547
-279,784
-17% -$22.3M 0.2% 142
2021
Q3
$121M Buy
1,608,331
+10,035
+0.6% +$763K 0.26% 129
2021
Q2
$124M Buy
1,598,296
+239,020
+18% +$17.8M 0.27% 120
2021
Q1
$100M Buy
1,359,276
+69,061
+5% +$5.09M 0.24% 132
2020
Q4
$101M Buy
1,290,215
+6,221
+0.5% +$476K 0.26% 110
2020
Q3
$102M Buy
1,283,994
+114,398
+10% +$8.96M 0.3% 99
2020
Q2
$86.3M Buy
1,169,596
+44,562
+4% +$3.35M 0.27% 98
2020
Q1
$82.6M Buy
1,125,034
+138,016
+14% +$10.8M 0.33% 88
2019
Q4
$85.7M Sell
987,018
-21,307
-2% -$1.75M 0.28% 101
2019
Q3
$81M Buy
1,008,325
+20,913
+2% +$1.68M 0.29% 106
2019
Q2
$79M Buy
987,412
+157,273
+19% +$12M 0.27% 114
2019
Q1
$65.9M Buy
830,139
+22,743
+3% +$1.7M 0.25% 124
2018
Q4
$58.9M Buy
807,396
+732,156
+973% +$51.7M 0.26% 114
2018
Q3
$5.09M Buy
75,240
+3,588
+5% +$229K 0.02% 266
2018
Q2
$4.15M Sell
71,652
-21,861
-23% -$1.23M 0.02% 298
2018
Q1
$4.86M Sell
93,513
-992,572
-91% -$53.6M 0.02% 299
2017
Q4
$58.3M Sell
1,086,085
-4,200
-0.4% -$233K 0.23% 113
2017
Q3
$66.6M Sell
1,090,285
-138,013
-11% -$8.37M 0.27% 111
2017
Q2
$75.1M Sell
1,228,298
-16,635
-1% -$1.01M 0.3% 102
2017
Q1
$75.5M Sell
1,244,933
-534,869
-30% -$32.5M 0.31% 94
2016
Q4
$100M Buy
1,779,802
+336,492
+23% +$19.7M 0.46% 86
2016
Q3
$86M Sell
1,443,310
-1,014,813
-41% -$59.3M 0.43% 87
2016
Q2
$135M Sell
2,458,123
-429,656
-15% -$22.9M 0.74% 38
2016
Q1
$146M Sell
2,887,779
-553,094
-16% -$27.1M 0.82% 28
2015
Q4
$173M Buy
3,440,873
+21,009
+0.6% +$1.06M 0.97% 25
2015
Q3
$161M Buy
3,419,864
+234,292
+7% +$12.4M 0.92% 25
2015
Q2
$173M Sell
3,185,572
-9,540
-0.3% -$535K 0.9% 28
2015
Q1
$175M Buy
3,195,112
+567,320
+22% +$32.1M 0.89% 37
2014
Q4
$142M Buy
2,627,792
+574,438
+28% +$32M 0.77% 33
2014
Q3
$116M Buy
2,053,354
+75,390
+4% +$4.23M 0.66% 46
2014
Q2
$109M Buy
1,977,964
+252,728
+15% +$13.8M 0.67% 48
2014
Q1
$93.5M Buy
1,725,236
+369,891
+27% +$19.2M 0.63% 63
2013
Q4
$64.7M Buy
1,355,345
+376,700
+38% +$17.2M 0.46% 83
2013
Q3
$44.5M Buy
978,645
+863,723
+752% +$39.4M 0.36% 90
2013
Q2
$5.09M Buy
+114,922
New +$5.13M 0.05% 195

Other funds holding MRK

Bessemer Group's MRK Position: Q1 2026 in Review

Bessemer Group reduced its Merck (MRK) stake by 47% in Q1 2026, selling an estimated $112M and leaving 1,081,897 shares worth $130M. The position accounts for 0.2% of the portfolio, ranked #123.

Bessemer Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $254M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bessemer Group held 1,081,897 shares of Merck worth $130M as of Q1 2026.
  • Bessemer Group sold 972,240 Merck shares in Q1 2026, an estimated $112M.
  • Merck made up 0.2% of Bessemer Group's portfolio in Q1 2026, its #123 holding.
  • Bessemer Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Bessemer Group's Merck position peaked at $254M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.